Navigation Links
Poor prenatal nutrition permanently damages function of insulin-producing cells in the pancreas

the third week, restricted to only half the amount. It had a dramatic effect. At birth, their babies weighed 23 percent less than the control group.

After delivery, all babies nursed and all mothers ate a full diet. "By the time the babies were weaned, at three weeks, the low-birth-weight group had caught up with the others, something we see in human babies too," said Dr. Patti. "They looked and acted the same. There was nothing outwardly different about them." The two groups of offspring ate the same chow diet, maintained a similar weight, and neither group was allowed to become overweight, eliminating this common risk factor for diabetes. The only difference was that the mothers had been fed differently during the final week.

As the young mice matured, the researchers tested their blood glucose (sugar) after meals. At age 2 months, the results were similar between the two groups. But over time, differences began to unfold. When 4 months old (comparable to human adolescence), the low-birth-weight babies began showing higher levels of blood glucose. "By 6 months, these levels had spiked abnormally, to 500 mg/dl -- the equivalent of serious, full-blown diabetes in humans," Dr. Patti said.

In type 1 diabetes, the pancreas cannot make the hormone insulin at all; about 1 million Americans must control this form by taking insulin injections. In type 2 -- a disorder affecting an estimated 18 million Americans -- the pancreas doesn't make enough insulin or the body's cells develop a resistance to its effect. Without insulin, glucose cannot get into cells to provide energy.

Normally, insulin levels rise or drop in response to glucose levels, keeping everything in balance. But diabetes is a complex metabolic disorder with numerous players such as high levels of blood glucose, cholesterol and other lipids. "The challenge is to figure out which factors are a primary cause of diabetes and which are a consequence, said Dr. Patti. "In our study, w
'"/>

Source:Joslin Diabetes Center


Page: 1 2 3 4

Related biology news :

1. PET/MRI scans may help unravel mechanisms of prenatal drug damage
2. Study finds that nutritionally enhanced rice reduces iron deficiency
3. Mother birds give a nutritional leg up to chicks with unattractive fathers
4. Soil nutrition affects carbon sequestration in forests
5. Used in a new way, RNA interference permanently silences key breast cancer gene
6. Smoking damages key regulatory enzyme in the lung
7. Automatic extraction of gene/protein biological functions from biomedical text
8. New research questions basic tenet of neuron function
9. Vascular structure and function improve with diet and exercise
10. Towards precise classification of cancers based on robust gene functional expression profiles
11. Researchers reveal secret of key protein in brain and heart function

Post Your Comments:
(Date:11/23/2009)...gton, CT Current research suggests that a common ... The related report by Nichols et al, "Unique Lipi...lass of TLR2 Ligands Capable of Enhancing Autoimmu...American Journal of Pathology . , Multiple scler...ks the brain and spinal cord, affects nearly 1 in ...
(Date:11/23/2009)..., Iowa - The only swine vaccine available for the ... infected with the virus. The vaccination marks th... diagnosed with the pandemic flu., Iowa State Un...e, developed the vaccine this summer and has been ...wa, Kansas and Illinois for several weeks., The ...
(Date:11/23/2009)...N, WI, November 16, 2009 -- A USDOE and USDA study... idle cropland, and cropland pasture could be conv...nial grasses, such as switchgrass, from which biom...ock. Economically viable production of a perennial...es of biomass are removed annually is expected to ...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Switchgrass produces biomass efficiently 2Labopharm amends debt facility agreement with Hercules 50014 1Labopharm amends debt facility agreement with Hercules 50014 2Labopharm amends debt facility agreement with Hercules 50014 3Richard A Meier Appointed to STAAR Surgical Board of Directors 50011 1Richard A Meier Appointed to STAAR Surgical Board of Directors 50011 2Richard A Meier Appointed to STAAR Surgical Board of Directors 50011 3Richard A Meier Appointed to STAAR Surgical Board of Directors 50011 4OptoElectronix Offers Lighting Manufacturers A Unique Integrated LED Light Engine With 1 000 Lumens Light Output 50007 1OptoElectronix Offers Lighting Manufacturers A Unique Integrated LED Light Engine With 1 000 Lumens Light Output 50007 2OptoElectronix Offers Lighting Manufacturers A Unique Integrated LED Light Engine With 1 000 Lumens Light Output 50007 3
...To help improve the success of oyster restoration ...and Center for Environmental Science researcher Dr...in a new in-depth study to determine when oysters ...ver. Her team,s research is supported by a $750,00...dation. , Working with fellow UMCES Horn Point La...
...f women with breast cancer today are candidates fo... their breast tissue. Results of a UC Davis study,... recurs in the same breast are treated with a seco...rrent treatment recommendations and cutting the nu... were surprised to find that so many women in our ...
..., the oil industry will need more refined tools fo...before taken place, geologists say. , One such to...ment-on-the-move is deposited), derived from sedim... ago, scientists report in this week,s issue of th... entire Paleozoic Era. , "The new Paleozoic sea-l...
Other Biology News:Second lumpectomy for breast cancer reduces survival rates 2Paleozoic 'sediment curve' provides new tool for tracking sea-floor sediment movements 2
(Date:11/25/2009)... BEIJING, Nov. 25 /PRNewswire-Asia/ -- Sinovac B...er of vaccines, announced today that it executed,a... (Dalian) Vaccine,Technology Co., Ltd. (Sinovac Da...commercialize human-use vaccines. Sinovac will con... and commercializing world-class vaccines; the,oth...
(Date:11/24/2009)... Ambassador to also Visit Detroit , ...Who: David Appia, French Ambassador for Internatio... in France Agency, , , , ,What: Ambassador Appia ...pro-business initiatives adopted by France to furt...dscape for innovation and development., , ,When: A...
(Date:11/24/2009)...OUIS, Nov. 24 Sigma-Aldr...g at the NASDAQ OMX conference on Tuesday, Decembe...terested parties may listen via live audio broadca... tor.sig m a a ldrich.com/ . Users can clic... About Sigma-Aldrich: Sigma-Aldrich is a leadin...
(Date:11/24/2009)... SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- Shanghai B... Administration (SFDA) has approved the,investigat...lin project,(Nodlin), an innovative insulin formul...Biolaxy to initiate its first phase I clinical stu...ic of high blood glucose and poor,metabolism. The ...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Biolaxy Secures IND Approval for Oral Insulin 2
... the Recently Released Strong Results from the, La...ore Human Appendicitis Blood- ba.... 4 AspenBio Pharma,Inc. (Nasdaq: APPY ) an emer...evelopment of novel drugs and diagnostics for anim... Edgewater Research Investor Conference, scheduled...
...dle (Nasdaq: KNDL ), a,leading, global full-servi... that President and Chief Operating Officer Christ...eichroeder Hidden Gems Conference. The,conference ...ew York City,Oct. 8-9, 2007. Kendle,s presentation...ern Time. (Logo: http://www.newscom.com/cgi-bin/...
... Acquisition Corp. (OTC,Bulletin Board: ACAQ), a s...a definitive agreement to acquire Lumen Medical In...opment stage biotechnology company that is,develop... the diagnosis of,Pulmonary Embolism, Pulmonary Hy...e trade name PulmoBind. Under the terms of the agr...
Other Biology Technology:AspenBio Pharma to Present the Edgewater Research Investor Conference 2Kendle to Present at the Natixis Bleichroeder Hidden Gems Conference 2Acorn Acquisition Corp Announces Definitive Agreement to Acquire Lumen Medical Inc. 2Acorn Acquisition Corp Announces Definitive Agreement to Acquire Lumen Medical Inc. 3Acorn Acquisition Corp Announces Definitive Agreement to Acquire Lumen Medical Inc. 4
Anti-Monocarboxylate Transporter 2 (MCT2) Polyclonal Antibody, Unconjugated from CHEMICON
Mouse Anti-Human Relaxin-2, pro- Monoclonal Antibody, Unconjugated, Clone fred from Immundiagnostik
Rabbit Anti-Chicken IgY, IgG F(ab')2 fragment Antibody, Biotin Conjugated from Biomeda Corporation
Anti-Chloride Channel, CLC-2 Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products: